CIBC World Markets’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$129K Sell
12,964
-16,268
-56% -$171K ﹤0.01% 1367
2025
Q1
$379K Buy
29,232
+16,904
+137% +$224K ﹤0.01% 1136
2024
Q4
$157K Buy
+12,328
New +$149K ﹤0.01% 1162

Other funds holding DVAX

CIBC World Markets's DVAX Position: Q2 2025 in Review

CIBC World Markets reduced its Dynavax Technologies (DVAX) stake by 56% in Q2 2025, selling an estimated $171K and leaving 12,964 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #1367.

CIBC World Markets first reported a position in DVAX in Q4 2024 and has held it in 3 quarters since. The position peaked at $379K in Q1 2025. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • CIBC World Markets held 12,964 shares of Dynavax Technologies worth $129K as of Q2 2025.
  • CIBC World Markets sold 16,268 Dynavax Technologies shares in Q2 2025, an estimated $171K.
  • Dynavax Technologies made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1367 holding.
  • CIBC World Markets first reported a position in Dynavax Technologies in Q4 2024 and has held it in 3 quarters since.
  • CIBC World Markets's Dynavax Technologies position peaked at $379K in Q1 2025.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.